Ani Pharmaceuticals Inc. (ANIP)
NASDAQ · Healthcare
Ani Pharmaceuticals Inc. Total Liabilities 2009–2025
Ani Pharmaceuticals Inc. annual total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Ani Pharmaceuticals Inc. total liabilities as of December 31, 2025: 899.7M, a 5.11% increase year-over-year.
- Ani Pharmaceuticals Inc. total liabilities for 2025 were 899.7M, a 5.11% increase from 2024.
- Ani Pharmaceuticals Inc. total liabilities for 2024 were 855.9M, a 91.56% increase from 2023.
- Ani Pharmaceuticals Inc. total liabilities for 2023 were 446.8M, a 6.00% increase from 2022.
- Ani Pharmaceuticals Inc. total liabilities for 2022 were 421.5M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Ani Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $900 |
| 2024 | $856 |
| 2023 | $447 |
| 2022 | $422 |
| 2021 | $413 |
| 2020 | $265 |
| 2019 | $244 |
| 2018 | $233 |
| 2017 | $237 |
| 2016 | $153 |
| 2015 | $125 |
| 2014 | $120 |
| 2013 | $4 |
| 2012 | $11 |
| 2011 | $25 |
Ani Pharmaceuticals Inc. Total Liabilities — FAQ
Ani Pharmaceuticals Inc. (ANIP) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ANIP's total liabilities history?
The chart and table above show Ani Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.